Life Cycle Management Strategies - Optimizing revenues and defending generic competition

Life Cycle Management Strategies - Optimizing revenues and defending generic competition

Summary

GBI Research's latest report, "Life Cycle Management Strategies - Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.

Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.

Full Report Details at
- http://www.fastmr.com/prod/1038159_life_cycle_management.aspx?afid=301

Scope

* Introduction of LCM and product life cycle
* Objectives of LCM and factors impacting the choice of strategies
* LCM strategies depending on the way of approach
* Impact of LCM strategies on sales and growth trend of selected products
* Patent term extension and market exclusivity in the US and Europe
* LCM strategies of pipeline drugs of key players
* Keys to successful implementation of LCM strategies

Key Reasons to Purchase

* Identify the key LCM strategies used by most of the pharmaceutical companies
* Analyze the strategies to increase lifecycle and revenues of a drug
* Gain an understanding on the implementation of multiple strategies for a single product by including case studies
* Understand the operational pipeline strategies of key players

Companies Mentioned in this Report: AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023
- PharmaLeaders: Global Pharmaceutical Market Benchmark Report - Retrospective and Forward-Looking Analysis of the Leading Pharmaceutical Companies
- Weight Loss and Weight Management Market - Forecast to 2019
- Asia Revenue Cycle Management System (RCM) Market - Analysis and Forecast to 2019